DK52687A - Hidtil ukendte 2-amino-3-formylfuraner, fremgangsmaader til deres fremstilling og farmaceutiske sammensaetninger, der indeholder disse forbindelser - Google Patents

Hidtil ukendte 2-amino-3-formylfuraner, fremgangsmaader til deres fremstilling og farmaceutiske sammensaetninger, der indeholder disse forbindelser

Info

Publication number
DK52687A
DK52687A DK052687A DK52687A DK52687A DK 52687 A DK52687 A DK 52687A DK 052687 A DK052687 A DK 052687A DK 52687 A DK52687 A DK 52687A DK 52687 A DK52687 A DK 52687A
Authority
DK
Denmark
Prior art keywords
furanes
relationships
procedures
amino
formula
Prior art date
Application number
DK052687A
Other languages
Danish (da)
English (en)
Other versions
DK52687D0 (da
Inventor
Walter Loesel
Otto Roos
Gerd Schnorrenberg
Dietrich Arndts
Franz-Jozef Kuhn
Erich Lehr
Richard Reichl
Guenter Schingnitz
Georg Speck
Original Assignee
Boehringer Ingelheim Kg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Kg filed Critical Boehringer Ingelheim Kg
Publication of DK52687D0 publication Critical patent/DK52687D0/da
Publication of DK52687A publication Critical patent/DK52687A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/08Vasodilators for multiple indications
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
DK052687A 1986-02-03 1987-02-02 Hidtil ukendte 2-amino-3-formylfuraner, fremgangsmaader til deres fremstilling og farmaceutiske sammensaetninger, der indeholder disse forbindelser DK52687A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19863603194 DE3603194A1 (de) 1986-02-03 1986-02-03 Neue 2-amino-3-formyl-furane, verfahren zu ihrer herstellung und die enthaltenden pharmazeutischen zusammensetzungen

Publications (2)

Publication Number Publication Date
DK52687D0 DK52687D0 (da) 1987-02-02
DK52687A true DK52687A (da) 1987-08-04

Family

ID=6293224

Family Applications (1)

Application Number Title Priority Date Filing Date
DK052687A DK52687A (da) 1986-02-03 1987-02-02 Hidtil ukendte 2-amino-3-formylfuraner, fremgangsmaader til deres fremstilling og farmaceutiske sammensaetninger, der indeholder disse forbindelser

Country Status (16)

Country Link
EP (1) EP0234329A1 (ja)
JP (1) JPS62185086A (ja)
KR (1) KR870007922A (ja)
AU (1) AU6823587A (ja)
CS (1) CS67287A2 (ja)
DD (1) DD260067A5 (ja)
DE (1) DE3603194A1 (ja)
DK (1) DK52687A (ja)
FI (1) FI870435A (ja)
HU (1) HU900157D0 (ja)
IL (1) IL81447A0 (ja)
NO (1) NO870408L (ja)
PL (1) PL263934A1 (ja)
PT (1) PT84240B (ja)
YU (1) YU13787A (ja)
ZA (1) ZA87730B (ja)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3143876A1 (de) * 1981-11-05 1983-05-11 Boehringer Ingelheim KG, 6507 Ingelheim Neue1-furyl-3,4-dihydroisochinoline diese enthaltende arzneimittel sowie verfahren zu deren herstellung und deren verwendung
DE3401018A1 (de) * 1984-01-13 1985-07-18 Boehringer Ingelheim KG, 6507 Ingelheim Verfahren zur herstellung von 5,6-dihydro-pyrrolo(2,1-a)isochinolinen

Also Published As

Publication number Publication date
PT84240B (pt) 1991-02-08
HU900157D0 (en) 1990-03-28
ZA87730B (en) 1988-10-26
KR870007922A (ko) 1987-09-22
CS67287A2 (en) 1990-10-12
JPS62185086A (ja) 1987-08-13
AU6823587A (en) 1987-08-06
EP0234329A1 (de) 1987-09-02
IL81447A0 (en) 1987-09-16
DE3603194A1 (de) 1987-08-06
HUT47100A (en) 1989-01-30
DD260067A5 (de) 1988-09-14
FI870435A (fi) 1987-08-04
PT84240A (de) 1987-03-01
FI870435A0 (fi) 1987-02-02
NO870408L (no) 1987-08-04
DK52687D0 (da) 1987-02-02
PL263934A1 (en) 1988-07-21
NO870408D0 (no) 1987-02-02
YU13787A (en) 1988-10-31

Similar Documents

Publication Publication Date Title
DK110886A (da) Hidtil ukendte sulfonylaminoforbindelser, fremgangsmaader til deres fremstilling, og farmaceutiske praeparater, der indeholder forbindelserne
DK573384D0 (da) Sphingosinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende disse derivater
DK445084A (da) 6-flour-1,4-dihydro-4-oxo-7-substituerede piperazinylquinolin-3-carboxylsyrederivater, fremgangsmaade til fremstilling af samme og farcaceutiske sammensaetninger indeholdende samme
DK165949C (da) 1,4-dihydropyridinderivater, fremgangsmaader til fremstilling deraf og farmaceutiske praeparater indeholdende forbindelserne
DK362787D0 (da) Benzensulfonamido-indanylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling
DK93685A (da) Benzisoselenazolthioner, fremgangsmaade til fremstilling af disse forbindelser og farmaceutiske praeparater indeholdende disse forbindelser
DK250387D0 (da) Di- og tetrahydroisoquinolin-derivater, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
DK219685A (da) Heterocycliske forbindelser, deres fremstilling og anvendelse som laegemidler
DK489378A (da) 6-oxygenerede-3,20-dioxopregnanderivater samt fremgangsmaade til fremstilling der af og farmaceutiske kompositioner indeholdende disse
DK457787A (da) Sulfonamidoethylforbindelser, laegemidler indeholdende disse forbindelser og fremgangsmaade til deres fremstilling
DK572785D0 (da) Imidazolderivater, laegemidler indeholdende disse forbindelser og fremgangsmaader til deres fremstilling
DK635988D0 (da) 1,3-butandiolacetoacetat-derivater og anvendelse af 1,3-butandiolacetoacetat-forbindelser til fremstilling af farmaceutiske praeparater
DK395788A (da) Oploeselige silybinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
DK0427526T3 (da) Pyridinderivater, fremgangsmåder til deres fremstilling og farmaceutiske præparater med indhold deraf
DK330687D0 (da) Forbindelser og farmaceutiske kompositioner, der er anvendelige som cardiotoniske midler
DK52687A (da) Hidtil ukendte 2-amino-3-formylfuraner, fremgangsmaader til deres fremstilling og farmaceutiske sammensaetninger, der indeholder disse forbindelser
DK165181C (da) Heterocycliske disulfider fremgangsmaade til deres fremstilling og farmaceutiske midler, der indeholdr disse forbindelser
DK512185D0 (da) 3,4-diazolderivater, fremgangsmaade til deres fremstilling og laegemidler, der indeholder disse forbindelser
DK127086A (da) Substituerede 1,8-naphthyridoner, fremgangsmaader til deres fremstilling og farmaceutiske kompositioner, der indeholder disse forbindelser
DK400085D0 (da) Aminosyrederivater, fremgangsmaader til fremstilling heraf og laegemidler indeholdende saadanne derivater
DK603085D0 (da) N-(2-hydroxyalkyl)-aminosyre og deres derivater, fremgangsmaader til fremstilling deraf og laegemidler indeholdende saadanne forbindelser
DK339285D0 (da) Pyridinderivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne
DK454185D0 (da) Aminosyrederivater, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner
DK554382A (da) 1,4-tiazankaboxylsyrederivater, deres fremstilling og anvendelse og praeparater hvori disse derivater er til stede
DK551183A (da) Substituerede 9h-8-oxo-pyrimido(2,1-f)purin-2,4-dioner, fremgangsmaade til deres fremstilling og farmaceutiske kompositioner indeholdende forbindelserne

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment